Global Ectoparasiticides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Ectoparasiticides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
An ectoparasiticide is an antiparasitic drug used in the treatment of ectoparasitic infestations. Commonly used ectoparasites are Baishenning, sulfur, lindane, DDT, benzyl benzoate, ivermectin and clomiphene.
Ectoparasiticides report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ectoparasiticides market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Dogs and Cats are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ectoparasiticides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Ectoparasiticides key manufacturers include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Inc., Sanofi, Virbac and Vetoquinol S.A., etc. Bayer, MSD Animal Health, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Ectoparasiticides can be divided into Permethrin, Sulfur, Lindane and Dicophane, etc. Permethrin is the mainstream product in the market, accounting for % sales share globally in 2022.
Ectoparasiticides is widely used in various fields, such as Dogs, Cats, Cattle and Pigs, etc. Dogs provides greatest supports to the Ectoparasiticides industry development. In 2022, global % sales of Ectoparasiticides went into Dogs filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Ectoparasiticides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis, Inc.
Sanofi
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals Plc
Advance Properties OOD/Huvepharma
Segment by Type
Permethrin
Sulfur
Lindane
Dicophane
Benzyl Benzoate
Ivermectin
Crotamiton
Others
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ectoparasiticides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ectoparasiticides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ectoparasiticides industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Ectoparasiticides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ectoparasiticides introduction, etc. Ectoparasiticides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Ectoparasiticides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Ectoparasiticides report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ectoparasiticides market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Dogs and Cats are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ectoparasiticides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Ectoparasiticides key manufacturers include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Inc., Sanofi, Virbac and Vetoquinol S.A., etc. Bayer, MSD Animal Health, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Ectoparasiticides can be divided into Permethrin, Sulfur, Lindane and Dicophane, etc. Permethrin is the mainstream product in the market, accounting for % sales share globally in 2022.
Ectoparasiticides is widely used in various fields, such as Dogs, Cats, Cattle and Pigs, etc. Dogs provides greatest supports to the Ectoparasiticides industry development. In 2022, global % sales of Ectoparasiticides went into Dogs filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Ectoparasiticides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis, Inc.
Sanofi
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals Plc
Advance Properties OOD/Huvepharma
Segment by Type
Permethrin
Sulfur
Lindane
Dicophane
Benzyl Benzoate
Ivermectin
Crotamiton
Others
Segment by Application
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ectoparasiticides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ectoparasiticides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ectoparasiticides industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Ectoparasiticides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ectoparasiticides introduction, etc. Ectoparasiticides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Ectoparasiticides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.